目次

1. Report Overview
1.1 Introduction to Gene Therapy R&D Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 COVID-19 Impact: Recovery Scenarios
1.6.2 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2 Executive Summary
2.1 Gene Therapy Has Experienced a Renaissance in Last 5 Years

3 Market Dynamics
3.1 Drivers
3.1.1 Robust Gene Therapy Pipeline to Boost Growth
3.1.2 Technological Advancements to Fuel Market Growth
3.1.3 Increasing Investments by Major Players
3.1.4 Growing Prevalence of Targeted Diseases Treatment
3.2 Restraints/Challenges
3.2.1 Cell & Gene Therapies Target Specific Diseases
3.2.2 High Cost to Stifle Gene Therapy R&D Growth Through 2031
3.2.3 Regulatory Scenarios to Challenge Industry Growth
3.3 Opportunities
3.3.1 Growing Number of Clinical Trials to Offer Lucrative Growth Opportunities
3.3.2 Facility Expansion Anticipated to Offer Lucrative Growth Prospects
3.4 Industry analysis - Porter’s
3.4.1 Buyer Power
3.4.2 Supplier Power
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitute
3.4.5 Threat of New Entrants
3.5 Industry analysis - PEST Analysis
3.5.1 Political Factors Impacting Gene Therapy R&D Market
3.5.2 Economic Factors Impacting Gene Therapy R&D Market
3.5.3 Social Factors Impacting Gene Therapy R&D Market
3.5.4 Technological Factors Impacting Gene Therapy R&D Market

4 Gene Therapy R&D Market by Disease
4.1 Cancer Segment Market Forecast, 2021-2031
4.1.1 Gene Therapy Interventions Have the Potential to Correct Molecular Defects That Contribute to Cancer Progression
4.1.2 Gene Therapy R&D Forecast for Cancer Segment, Recovery Scenarios (V, U, W, L)
4.2 Rare Diseases Sub-Segment Market Forecast, 2021-2031
4.2.1 Economic Burden of Rare Diseases to Fuel Segmental Growth
4.2.2 Gene Therapy R&D Forecast for Rare Diseases Segment, Recovery Scenarios (V, U, W, L)
4.3 Cardiovascular Diseases Segment Market Forecast, 2021-2031
4.3.1 Rising CVDs Patient Pool to Augur Segmental Growth
4.3.2 Gene Therapy R&D Forecast for CVDs Segment, Recovery Scenarios (V, U, W, L)
4.4 Ophthalmic Diseases Segment Market Forecast, 2021-2031
4.4.1 Gene Therapy Making Progress in Ophthalmology
4.4.2 Gene Therapy R&D Forecast for Ophthalmic Diseases Segment, Recovery Scenarios (V, U, W, L)
4.5 Hematology Segment Market Forecast, 2021-2031
4.5.1 Growing Burden of Blood Related Disorders to Boost Segment Growth
4.5.2 Selected Gene Therapy Amenable Hematological Disorders
4.5.3 Companies Developing Gene Therapies for Hematological Disorders
4.5.4 Gene Therapy R&D Forecast for Hematology Segment, Recovery Scenarios (V, U, W, L)
4.6 Neurological Segment Market Forecast, 2021-2031
4.6.1 Adeno-associated viral (AAV) vectors are a rapidly emerging gene therapy platform for the treatment of neurological diseases
4.6.2 Gene Therapy R&D Forecast for Neurological Segment, Recovery Scenarios (V, U, W, L)
4.7 Diabetes Mellitus Segment Market Forecast, 2021-2031
4.7.1 Gene Therapy R&D Forecast for Diabetes Mellitus Segment, Recovery Scenarios (V, U, W, L)
4.8 Other Diseases Segment Market Forecast, 2021-2031
4.8.1 Gene Therapy R&D Forecast for Others Segment, Recovery Scenarios (V, U, W, L)

5 Gene Therapy R&D Market by Vector
5.1 Viral Sub-Segment Market Forecast, 2021-2031
5.1.1 Facility Expansion by Major Players to Fuel Viral Sub-Segment Industry Growth
5.1.2 Retrovirus
5.1.3 Adenovirus
5.1.4 AAV (Adeno-Associated Virus)
5.1.5 Lentivirus
5.1.6 Others
5.1.7 Gene Therapy R&D Forecast for Viral Segment, Recovery Scenarios (V, U, W, L)
5.2 Non-Viral Sub-Segment Market Forecast, 2021-2031
5.2.1 Growing Research Focus on Developing Optimal Delivery Method to Fuel Sub-Segment Growth
5.2.2 Naked DNA
5.2.3 Gene-Gun
5.2.4 Electroporation
5.2.5 Gene Therapy R&D Forecast for Non-Viral Segment, Recovery Scenarios (V, U, W, L)

6 Gene Therapy R&D Market by Techniques
6.1 Gene Augmentation Therapy Segment Market Forecast, 2021-2031
6.1.1 Gene Therapy R&D Forecast for Gene Augmentation Segment, Recovery Scenarios (V, U, W, L)
6.2 Gene Replacement Therapy Segment Market Forecast, 2021-2031
6.2.1 Gene Therapy R&D Forecast for Gene Replacement Segment, Recovery Scenarios (V, U, W, L)

7 Regional and Leading National Gene Therapy R&D Market Forecasts 2021-2031
7.1 Global Gene Therapy R&D Market by Region Forecast 2021-2031
7.2 Recovery Scenarios (V, U, W, L): Gene Therapy R&D Market Forecast by Region, 2021-2031

8 North America Gene Therapy R&D Market
8.1 North America Currently Dominates the Global Gene Therapy R&D Market
8.2 North America Gene Therapy R&D Market by Country, Forecast 2021-2031
8.3 North America Gene Therapy R&D Market Forecast by Disease
8.3.1 Recovery Scenarios (V, U, W, L): North America Gene Therapy R&D Market Forecast by Disease, 2021-2031
8.4 North America Gene Therapy R&D Market Forecast by Vector
8.4.1 Recovery Scenarios (V, U, W, L): North America Gene Therapy R&D Market Forecast by Vector, 2021-2031
8.5 North America Gene Therapy R&D Market Forecast by Techniques
8.5.1 Recovery Scenarios (V, U, W, L): North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031
8.6 U.S. Gene Therapy R&D Market Forecast, 2021-2031
8.6.1 U.S. Currently Dominating the North American Gene Therapy R&D Market
8.6.2 Increasing Prevalence of Genetic Disorders Anticipated to Fuel Regional Growth
8.6.3 Recovery Scenarios (V, U, W, L): U.S. Gene Therapy R&D Market Forecast, 2021-2031
8.7 Canada Gene Therapy R&D Market Forecast, 2021-2031
8.7.1 Significant Growth Opportunities Due to Increasing Cancer Burden
8.7.2 Growing Geriatric Population to Fuel Demand for Gene Therapy R&D Through 2031
8.7.3 Recovery Scenarios (V, U, W, L): Canada Gene Therapy R&D Market Forecast, 2021-2031

9 Europe Gene Therapy R&D Market
9.1 Second Largest Gene Therapy R&D Industry Worldwide
9.2 Europe Gene Therapy R&D Market by Country, Forecast 2021-2031
9.3 Europe Gene Therapy R&D Market Forecast by Disease
9.3.1 Recovery Scenarios (V, U, W, L): Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031
9.4 Europe Gene Therapy R&D Market Forecast by Vector
9.4.1 Recovery Scenarios (V, U, W, L): Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031
9.5 Europe Gene Therapy R&D Market Forecast by Techniques
9.5.1 Recovery Scenarios (V, U, W, L): Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031
9.6 Germany Gene Therapy R&D Market Forecast, 2021-2031
9.6.1 Germany Currently Dominates the European Gene Therapy R&D Market
9.6.2 Rising Geriatric Patient Pool to Offer Lucrative Growth Prospects
9.6.3 Increasing in New Pipeline Developments for Gene Therapy to Boost German Gene Therapy R&D Market
9.6.4 Recovery Scenarios (V, U, W, L): Germany Gene Therapy R&D Market Forecast, 2021-2031
9.7 UK Gene Therapy R&D Market Forecast, 2021-2031
9.7.1 Rising Number of Clinical Trials to Boost UK Gene Therapy R&D Market Growth
9.7.2 Rising Cancer Burden to Boost Regional Growth Over the Forecast Period
9.7.3 Growing Burden of Genetic Disorders to Fuel Regional Growth Through 2031
9.7.4 Recovery Scenarios (V, U, W, L): UK Gene Therapy R&D Market Forecast, 2021-2031
9.8 France Gene Therapy R&D Market Forecast, 2021-2031
9.8.1 Increasing Incidence of Genetic Disorders to Fuel French Gene Therapy R&D Market Growth
9.8.2 Rising Cancer Incidence to Fuel Gene Therapy R&D Growth
9.8.3 Presence of Major Biotech Firms Across France to Offer Lucrative Growth Prospects
9.8.4 Recovery Scenarios (V, U, W, L): France Gene Therapy R&D Market Forecast, 2021-2031
9.9 Italy Gene Therapy R&D Market Forecast, 2021-2031
9.9.1 Italian Gene Therapy R&D Market to Surge Owing to Rising Healthcare Expenditure
9.9.2 Italian Gene Therapy R&D Set to Witness Tremendous Growth
9.9.3 Recovery Scenarios (V, U, W, L): Italy Gene Therapy R&D Market Forecast, 2021-2031
9.10 Spain Gene Therapy R&D Market Forecast, 2021-2031
9.10.1 Rising Cancer Burden to Fuel Spanish Gene Therapy R&D Industry Growth
9.10.2 Recovery Scenarios (V, U, W, L): Spain Gene Therapy R&D Market Forecast, 2021-2031
9.11 Russia Gene Therapy R&D Market Forecast, 2021-2031
9.11.1 Rising Cancer Incidence to Fuel Russian Gene Therapy R&D Market Growth
9.11.2 Government Focus to Establish Special Fund for Gene Therapy to Fuel Regional Growth
9.11.3 Recovery Scenarios (V, U, W, L): Russia Gene Therapy R&D Market Forecast, 2021-2031
9.12 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031
9.12.1 Finland Gene Therapy R&D Another Promising Market in Rest of Europe
9.12.2 Recovery Scenarios (V, U, W, L): Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031

10 Asia Pacific Gene Therapy R&D Market
10.1 Asia Pacific to Witness Highest Growth Rates Through 2031
10.2 Asia Pacific Gene Therapy R&D Market by Country, Forecast 2021-2031
10.3 Asia Pacific Gene Therapy R&D Market Forecast by Disease
10.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031
10.4 Asia Pacific Gene Therapy R&D Market Forecast by Vector
10.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031
10.5 Asia Pacific Gene Therapy R&D Market Forecast by Techniques
10.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031
10.6 Japan Gene Therapy R&D Market Forecast, 2021-2031
10.6.1 Japanese Gene Therapy R&D Market to Witness Highest CAGR Through 2031
10.6.2 Approval of Zolgensma by Japanese Government Anticipated to Boost Regional Growth
10.6.3 Ageing Japanese Population Anticipated to Offer Lucrative Growth Prospects Over the Next Decade
10.6.4 Recovery Scenarios (V, U, W, L): Japan Gene Therapy R&D Market Forecast, 2021-2031
10.7 China Gene Therapy R&D Market Forecast, 2021-2031
10.7.1 China Currently Accounts for Majority of the APAC Gene Therapy R&D Market Share
10.7.2 Strategic Collaboration to Fuel Chinese Gene Therapy R&D Market Over the Forecast Period
10.7.3 Recovery Scenarios (V, U, W, L): China Gene Therapy R&D Market Forecast, 2021-2031
10.8 India Gene Therapy R&D Market Forecast, 2021-2031
10.8.1 Burden of Genetic Disorders and Unmet Medical Needs to fuel Regional Gene Therapy R&D Industry Growth
10.8.2 India Continues to be a Key Player in Gene Therapy Related Research
10.8.3 Recovery Scenarios (V, U, W, L): India Gene Therapy R&D Market Forecast, 2021-2031
10.9 Australia Gene Therapy R&D Market Forecast, 2021-2031
10.9.1 Rising Chronic Disorders to Augur Australian Gene Therapy R&D Market Growth
10.9.2 Australia is Currently Undergoing Gene Therapy Clinical Trials to Treat a Variety of Genetic Health Conditions
10.9.3 Recovery Scenarios (V, U, W, L): Australia Gene Therapy R&D Market Forecast, 2021-2031
10.10 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031
10.10.1 SEA Economies Driving Rest of APAC Gene Therapy R&D Industry
10.10.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031

11 Latin America Gene Therapy R&D Market
11.1 Latin America Gene Therapy R&D Industry, One of the Emerging Regions Globally
11.1.1 Brazil First Among Latin American Economy to Approve Luxturna® and Zolgensma®
11.2 Latin America Gene Therapy R&D Market by Country, Forecast 2021-2031
11.3 Latin America Gene Therapy R&D Market Forecast by Disease
11.3.1 Recovery Scenarios (V, U, W, L): Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031
11.4 Latin America Gene Therapy R&D Market Forecast by Vector
11.4.1 Recovery Scenarios (V, U, W, L): Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031
11.5 Latin America Gene Therapy R&D Market Forecast by Techniques
11.5.1 Recovery Scenarios (V, U, W, L): Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031
11.6 Brazil Gene Therapy R&D Market Forecast, 2021-2031
11.6.1 Brazil Gene Therapy R&D Market to Witness Highest Growth Rate Across Latin American Region
11.6.2 Recovery Scenarios (V, U, W, L): Brazil Gene Therapy R&D Market Forecast, 2021-2031
11.7 Mexico Gene Therapy R&D Market Forecast, 2021-2031
11.7.1 Mexican Gene Therapy R&D Currently Dominating the Latin American Region
11.7.2 Burgeoning Ant-Aging Research to Offer Lucrative Growth Prospects
11.7.3 Recovery Scenarios (V, U, W, L): Mexico Gene Therapy R&D Market Forecast, 2021-2031
11.8 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031
11.8.1 Recovery Scenarios (V, U, W, L): Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031

12 Middle East and Africa Gene Therapy R&D Market
12.1 Growing Chronic Disease Patient Pool to Drive Demand for Gene Therapy R&D Industry Across MEA Region
12.2 Middle East and Africa Gene Therapy R&D Market by Country, Forecast 2021-2031
12.3 Middle East and Africa Gene Therapy R&D Market Forecast by Disease
12.3.1 Recovery Scenarios (V, U, W, L): MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031
12.4 Middle East and Africa Gene Therapy R&D Market Forecast by Vector
12.4.1 Recovery Scenarios (V, U, W, L): MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031
12.5 Middle East and Africa Gene Therapy R&D Market Forecast by Techniques
12.5.1 Recovery Scenarios (V, U, W, L): MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031
12.6 GCC Gene Therapy R&D Market Forecast, 2021-2031
12.6.1 Rising Burden of Chronic Diseases to Fuel GCC Gene Therapy R&D Market Growth
12.6.2 Luxturna Approval in UAE Anticipated to Boost Gene Therapy R&D Market Over the Next Decade
12.6.3 Recovery Scenarios (V, U, W, L): GCC Gene Therapy R&D Market Forecast, 2021-2031
12.7 South Africa Gene Therapy R&D Market Forecast, 2021-2031
12.7.1 South Africa Currently Dominates the MEA Gene Therapy R&D Market
12.7.2 Investment in South African Gene Therapy R&D Industry to Boost Regional Growth
12.7.3 Recovery Scenarios (V, U, W, L): South Africa Gene Therapy R&D Market Forecast, 2021-2031
12.8 Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031
12.8.1 Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031

13 Competitive Landscape
13.1 Strategic Choices for Winning in Gene Therapy R&D Market
13.1.1 Diversification of Technical Risks
13.1.2 How to Achieve Long Term Benefits to Patients
13.1.3 Building Digital Capabilities
13.1.4 Mergers & Acquisitions to Offer Lucrative Growth Prospects for Players Across the Value Chain
13.2 Approved Cellular & Gene Therapy Products as of March 2021
13.3 Ongoing Gene Therapy Clinical Trials by Companies
13.4 Gene Therapy Companies Market Capitalization

14 Company Profiles
14.1 UniQure B. V.
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis, 2015-2019
14.1.4 Pipeline: Gene Therapy
14.1.5 Recent Developments
14.2 Biogen
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis, 2015-2019
14.2.4 Product Benchmarking
14.2.5 Recent Developments
14.3 Bluebird Bio
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis, 2015-2019
14.3.4 Product Benchmarking
14.3.5 Recent Developments
14.4 Spark Therapeutics (Subsidiary of Roche)
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Product Benchmarking
14.4.4 Recent Developments
14.5 Bayer
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis, 2015-2020
14.5.4 Product Benchmarking
14.5.5 Recent Developments
14.6 Pfizer, Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis, 2015-2020
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.7 Applied Genetic
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis, 2015-2020
14.7.4 Product Benchmarking
14.7.5 Recent Developments
14.8 Oxford Biomedica
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis, 2015-2019
14.8.4 Product Pipeline
14.8.5 Recent Developments
14.9 GenSight Biologics
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.10 Takeda Pharmaceuticals
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis, 2015-2020
14.10.4 Product Benchmarking
14.10.5 Recent Developments
14.11 Cellectis
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis, 2015-2019
14.11.4 Product Benchmarking
14.11.5 Recent Developments
14.12 Sangamo Therapeutics, Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis, 2015-2019
14.12.4 Product Benchmarking
14.12.5 Recent Developments
14.13 REGENXBIO Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis, 2015-2019
14.13.4 Product Benchmarking
14.13.5 Recent Developments
14.14 Voyager Therapeutics
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis, 2015-2019
14.14.4 Product Benchmarking
14.14.5 Recent Developments
14.15 Bristol Myers Squibb
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis, 2015-2019
14.15.4 Product Benchmarking
14.15.5 Recent Developments
14.16 Benitec BioPharma
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis, 2015-2020
14.16.4 Product Benchmarking
14.17 F. Hoffmann-La Roche Ltd.
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis, 2015-2019
14.17.4 Product Benchmarking
14.17.5 Recent Developments
14.18 Novartis Gene Therapies
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis, 2015-2020
14.18.4 Product Benchmarking
14.18.5 Recent Developments
14.19 Gilead Lifesciences, Inc.
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Financial Analysis, 2015-2019
14.19.4 Product Benchmarking
14.20 Sanofi
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Financial Analysis, 2015-2019
14.20.4 Product Benchmarking
14.20.5 Recent Developments
14.21 Transgene
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Product Benchmarking
14.22 Calimmune, Inc. (CSL Behiring)
14.22.1 Company Snapshot
14.22.2 Company Overview
14.22.3 Product Benchmarking
14.22.4 Recent Developments
14.23 Astellas Pharma Inc.
14.23.1 Company Snapshot
14.23.2 Company Overview
14.23.3 Financial Analysis, 2015-2020
14.23.4 Product Benchmarking
14.24 American Gene Technologies
14.24.1 Company Snapshot
14.24.2 Company Overview
14.24.3 Product Benchmarking
14.25 Orchard Therapeutics
14.25.1 Company Snapshot
14.25.2 Company Overview
14.25.3 Product Benchmarking
14.25.4 Recent Developments

15 Conclusion
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players
15.3 Leading Region & Highest CAGR Grossing Region Snapshot, 2021 & 2031

List of Tables
Table 1 Global Gene Therapy R&D Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 1 Promising Therapies in Development
Table 2 Gene, Cell & Tissue Bases Therapeutic Developers Financings by IPOs, 2020
Table 3 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Follow-Ons, 2020
Table 4 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Venture Capital, 2020
Table 5 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Partnership, 2020
Table 6 Global Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 7 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 8 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 9 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 10 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 11 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 12 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 13 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 14 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 15 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 16 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 17 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 18 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 19 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 20 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 21 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 22 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 23 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 24 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 25 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 26 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 27 Selected Gene Therapy Amenable Hematological Disorders
Table 28 Selected Gene Therapy Amenable Hematological Disorders
Table 29 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 30 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 35 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 36 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 37 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 38 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 39 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 40 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 44 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 45 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 46 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 47 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 48 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 49 Global Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 51 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 56 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Global Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 60 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 61 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 66 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 71 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 North America Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 76 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 77 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 82 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 87 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 88 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 89 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 90 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 91 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 92 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 97 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Europe Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 102 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 103 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 104 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 105 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 106 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 107 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 108 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 109 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 110 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 111 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 112 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 113 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 114 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 115 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 116 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 117 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 118 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 119 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 120 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 121 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 122 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 123 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 124 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 125 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 126 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 127 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 128 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 129 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 130 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 131 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 132 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 133 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 138 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 139 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 140 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 141 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 142 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 143 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 144 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 145 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 146 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 147 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 148 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 149 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 150 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 151 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 152 Asia Pacific Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 153 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 154 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 159 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 163 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 164 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 165 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 166 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 167 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 168 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 169 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 170 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 171 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 172 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 173 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 174 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 175 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 176 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 177 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 178 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 179 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 180 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 181 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 182 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 183 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 184 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 185 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 186 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 187 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 188 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 189 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 190 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 191 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 192 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 193 Latin America Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 194 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 195 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 196 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 197 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 198 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 199 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 200 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 201 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 202 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 203 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 204 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 205 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 210 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 215 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 216 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 217 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 218 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 219 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 220 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 221 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 222 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 223 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 224 MEA Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 225 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 226 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 227 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 228 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 229 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 230 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 231 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 232 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 233 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 234 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 235 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 236 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 237 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 238 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 239 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 240 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 241 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 242 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 243 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 244 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 245 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 246 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 247 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 248 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 249 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 250 Rest of MEA Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 251 Rest of MEA Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 252 Rest of MEA Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 253 Rest of MEA Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 254 Rest of MEA Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 2 Approved Cellular & Gene Therapy Products as of March 2021
Table 3 Ongoing Gene Therapy Clinical Trials by Companies
Table 255 UniQure B. V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 256 UniQure B. V.: Product Benchmarking
Table 257 UniQure B. V.: Recent Developments
Table 258 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 259 Biogen: Product Benchmarking
Table 260 Biogen: Recent Developments
Table 261 Bluebird Bio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 262 Bluebird Bio: Product Benchmarking
Table 263 Bluebird Bio: Recent Developments
Table 264 Spark Therapeutics (Subsidiary of Roche): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 265 Spark Therapeutics: Product Benchmarking
Table 266 Spark Therapeutics: Recent Developments
Table 267 Bayer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 268 Bayer: Product Benchmarking
Table 269 Bayer: Recent Developments
Table 270 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 271 Pfizer Inc.: Product Benchmarking
Table 272 Pfizer Inc.: Recent Developments
Table 273 Applied Genetic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 274 Applied Genetic: Product Benchmarking
Table 275 Applied Genetic: Recent Developments
Table 276 Oxford Biomedica: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 277 Oxford Biomedica: Product Pipeline
Table 278 Oxford Biomedica: Recent Developments
Table 279 GenSight Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 280 GenSight Biologics: Product Benchmarking
Table 281 Takeda Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 282 Takeda Pharmaceuticals: Product Benchmarking
Table 283 Takeda Pharmaceuticals: Recent Developments
Table 284 Cellectis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 285 Cellectis: Product Benchmarking
Table 286 Cellectis: Recent Developments
Table 287 Sangamo Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 288 Sangamo Therapeutics, Inc.: Product Benchmarking
Table 289 Sangamo Therapeutics, Inc.: Recent Developments
Table 290 REGENXBIO Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 291 REGENXBIO Inc.: Product Benchmarking
Table 292 REGENXBIO Inc.: Recent Developments
Table 293 Voyager Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 294 Voyager Therapeutics: Product Benchmarking
Table 295 Voyager Therapeutics: Recent Developments
Table 296 Bristol Myers Squibb: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 297 Bristol Myers Squibb: Product Benchmarking
Table 298 Bristol Myers Squibb: Recent Developments
Table 299 Benitec BioPharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 300 Benitec BioPharma: Product Benchmarking
Table 301 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 302 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 303 F. Hoffmann-La Roche Ltd.: Recent Developments
Table 304 Novartis Gene Therapies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 305 Novartis AG: Product Benchmarking
Table 306 Novartis AG: Recent Developments
Table 307 Gilead Lifesciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 308 Gilead Lifesciences, Inc.: Product Benchmarking
Table 309 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 310 Sanofi: Product Benchmarking
Table 311 Sanofi: Recent Developments
Table 312 Transgene: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 313 Transgene: Product Benchmarking
Table 314 Calimmune, Inc. (CSL Behiring): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 315 Calimmune, Inc. (CSL Behiring): Product Benchmarking
Table 316 Calimmune, Inc. (CSL Behiring): Recent Developments
Table 317 Astellas Pharma Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 318 Astellas Pharma Inc.: Product Benchmarking
Table 319 American Gene Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 320 American Gene Technologies: Product Benchmarking
Table 321 Orchard Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 322 Orchard Therapeutics: Product Benchmarking
Table 323 Orchard Therapeutics: Recent Developments
?

List of Figures
Figure 1 Global Gene Therapy R&D Market: Market Segmentation
Figure 2 Global Gene Therapy R&D Market: Market Trends
Figure 3 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Deal Type, 2020
Figure 4 Porter’s Analysis
Figure 5 PEST Analysis
Figure 6 Global Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR %)
Figure 7 Global Gene Therapy R&D Market Share Forecast by Disease, 2021, 2026, 2031 (%)
Figure 8 Global Gene Therapy R&D Market for Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 9 Global Gene Therapy R&D Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 10 Global Gene Therapy R&D Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 11 Global Gene Therapy R&D Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 12 Global Gene Therapy R&D Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 13 Global Gene Therapy R&D Market for Rare Diseases Sub-Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 14 Global Gene Therapy R&D Market for Rare Diseases Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 15 Global Gene Therapy R&D Market for Rare Diseases Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 16 Global Gene Therapy R&D Market for Rare Diseases Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 17 Global Gene Therapy R&D Market for Rare Diseases Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 18 Global Gene Therapy R&D Market for Cardiovascular Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 19 Global Gene Therapy R&D Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 20 Global Gene Therapy R&D Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 21 Global Gene Therapy R&D Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 22 Global Gene Therapy R&D Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 23 Global Gene Therapy R&D Market for Ophthalmic Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 24 Global Gene Therapy R&D Market for Ophthalmic Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 25 Global Gene Therapy R&D Market for Ophthalmic Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 26 Global Gene Therapy R&D Market for Ophthalmic Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 27 Global Gene Therapy R&D Market for Ophthalmic Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 28 Global Gene Therapy R&D Market for Hematology Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 29 Global Gene Therapy R&D Market for Hematology Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 30 Global Gene Therapy R&D Market for Hematology Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 31 Global Gene Therapy R&D Market for Hematology Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 32 Global Gene Therapy R&D Mark